The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease.
This agent's immunosuppressive capabilities are being explored as a therapeutic approach for managing psoriasis and mitigating the risk of graft-versus-host disease.